PAVmed Inc (PAVMZ)
USD 0.02
(32.0%)
USD 0.02
(32.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -52.03 Million | -70.98 Million | -40.59 Million | -21.91 Million | -13.35 Million | -8.78 Million |
| Net Income | -64.17 Million | -103.23 Million | -56.12 Million | -35.88 Million | -17.26 Million | -18.17 Million |
| Depreciation & Amortization | 2.93 Million | 2.45 Million | 226 Thousand | 23 Thousand | 14.22 Thousand | 9790.00 |
| Deferred income taxes | 962 Million | - | 3.41 Million | 6.49 Million | 1.83 Million | 3.69 Million |
| Stock-based compensation | 11.13 Million | 19.53 Million | 15 Million | 2.04 Million | 1.57 Million | 1.22 Million |
| Change in working capital | 1.59 Million | -716 Thousand | -1.56 Million | 83 Thousand | -63.93 Thousand | 1.34 Million |
| Other non-cash items | -965.52 Million | 10.98 Million | -1.54 Million | 5.32 Million | 558.59 Thousand | 3.1 Million |
| Investing Cash Flow | 758 Thousand | -4.74 Million | -3.71 Million | -55 Thousand | -27.2 Thousand | -26.6 Thousand |
| Investments in PPE | -242 Thousand | -1.54 Million | -1.46 Million | -55 Thousand | -27.2 Thousand | -26.6 Thousand |
| Acquisitions | - | -3.2 Million | -2.24 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 1 Million | -3.2 Million | -2.24 Million | -55 Thousand | -27.2 Billion | -26.6 Thousand |
| Financing Cash Flow | 31.17 Million | 38.21 Million | 104.3 Million | 33 Million | 11.38 Million | 15.5 Million |
| Debt repayment | -9.92 Million | -35.22 Million | -14.97 Million | -600 Thousand | -364.75 Thousand | -5 Million |
| Dividends payments | - | - | - | - | - | -7099.00 |
| Common Stock Repurchased | 259 Million | -366 Thousand | 436 Million | 357 Thousand | 67.43 Billion | 16.43 Million |
| Common Stock Issuance | 21.25 Million | 1.88 Million | 119.27 Million | 16.03 Million | 5.54 Million | 4.41 Million |
| Other Financing Activities | 21.25 Million | 107.14 Million | 119.27 Million | 17.57 Million | 6.19 Million | -339.11 Thousand |
| Accounts receivables | -44 Thousand | 183 Thousand | -200 Thousand | - | - | - |
| Accounts payables | -918 Thousand | -742 Thousand | 174 Thousand | 501 Thousand | 613.28 Thousand | 872.11 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 2.55 Million | -157 Thousand | -1.54 Million | -418 Thousand | -677.21 Thousand | 474.2 Thousand |
| Cash at beginning of period | 39.74 Million | 77.25 Million | 17.25 Million | 6.21 Million | 8.22 Million | 1.53 Million |
| Cash at end of period | 19.63 Million | 39.74 Million | 77.25 Million | 17.25 Million | 6.21 Million | 8.22 Million |
| Capital Expenditure | -242 Thousand | -1.54 Million | -1.46 Million | -55 Thousand | -27.2 Thousand | -26.6 Thousand |
| Effect of forex changes on cash | -20.08 Billion | - | - | - | - | - |
| Net cash flow / Change in cash | -20.1 Million | -37.51 Million | 60 Million | 11.03 Million | -2 Million | 6.68 Million |
| Free Cash Flow | -52.27 Million | -72.52 Million | -42.06 Million | -21.96 Million | -13.38 Million | -8.81 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -10.82 Million | -15.21 Million | -64.17 Million | -14.03 Million | -21.74 Million | -17.89 Million |
| Depreciation & Amortization | 305 Thousand | 586 Thousand | 2.93 Million | 725 Thousand | 733 Thousand | 747 Thousand |
| Deferred income taxes | - | - | 962 Million | -3.82 Million | 1.79 Million | 1 Million |
| Stock-based compensation | 1.9 Million | 1.88 Million | 11.13 Million | 1.96 Million | 2.24 Million | 2.5 Million |
| Change in working capital | -422 Thousand | 378 Thousand | 1.59 Million | 2.12 Million | 1.38 Million | -154 Thousand |
| Other non-cash items | 302 Thousand | 2.61 Million | -965.52 Million | 1.16 Million | 4.5 Million | 1 Million |
| Investing Cash Flow | -3000.00 | -42 Thousand | 758 Thousand | -183 Thousand | -18 Thousand | -15 Thousand |
| Investments in PPE | -3000.00 | -42 Thousand | -242 Thousand | -183 Thousand | -18 Thousand | -15 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -42 Million | 1 Million | 757 Million | - | - |
| Financing Cash Flow | 11.62 Million | 19.04 Million | 31.17 Million | 5.28 Million | 352 Thousand | 684 Thousand |
| Debt repayment | -209 Thousand | -322 Thousand | -9.92 Million | -79 Thousand | - | -75 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | 62 Million | 259 Million | 77 Million | - | - |
| Common Stock Issuance | 11.83 Million | 19.37 Million | 21.25 Million | 5.36 Million | 352 Thousand | 609 Thousand |
| Other Financing Activities | -353 Thousand | 19.04 Million | 21.25 Million | 5.28 Million | 352 Thousand | 684 Thousand |
| Accounts receivables | -152 Thousand | -6000.00 | -44 Thousand | -26 Thousand | 6000.00 | -14 Thousand |
| Accounts payables | -252 Thousand | -301 Thousand | -918 Thousand | -380 Thousand | 1 Million | -97 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -18 Thousand | 685 Thousand | 2.55 Million | 2.53 Million | 374 Thousand | -43 Thousand |
| Cash at beginning of period | 25.53 Million | 19.63 Million | 39.74 Million | 26.4 Million | 37.16 Million | 49.28 Million |
| Cash at end of period | 25.49 Million | 25.53 Million | 19.63 Million | 19.63 Million | 26.4 Million | 37.16 Million |
| Capital Expenditure | -3000.00 | -42 Thousand | -242 Thousand | -183 Thousand | -18 Thousand | -15 Thousand |
| Effect of forex changes on cash | - | - | -20.08 Billion | -2.67 Billion | 1.26 Billion | 1.41 Billion |
| Net cash flow / Change in cash | -37 Thousand | 5.89 Million | -20.1 Million | -6.76 Million | -10.75 Million | -12.11 Million |
| Free Cash Flow | -11.65 Million | -13.15 Million | -52.27 Million | -12.05 Million | -11.1 Million | -12.8 Million |
LILA
DYN
AGSTRA
JINDCAP
SAMKRG
ICM